Clinical Trial Update: API-CAT STUDY for APIxaban Cancer Associated Thrombosis [Phase 3]

View source ↗

Summary

The Phase 3 API-CAT trial evaluating APIxaban for cancer-associated thrombosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-associated Thrombosis

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cancer-associated Thrombosis | Phase 3 | Status: COMPLETED